Improving – Onyx Phonix

(BPRW) Wolters Kluwer, Together with the Black Nurse Collaborative, Increases Focus on Improving Advocacy for Underrepresented Groups in Nursing | Press releases

(BPRW) Wolters Kluwer, Together with the Black Nurse Collaborative, Increases Focus on Improving Advocacy for Underrepresented Groups in Nursing The organizations look to enhance opportunities for Black nurses and advance health equity (Black PR Wire) WALTHAM, Mass.–(BUSINESS WIRE)– Wolters Kluwer Health today announced a new collaboration with the Black Nurse Collaborative, (BNC) to help remove barriers and improve diversity […]

(BPRW) Wolters Kluwer, Together with the Black Nurse Collaborative, Increases Focus on Improving Advocacy for Underrepresented Groups in Nursing | Press releases

(BPRW) Wolters Kluwer, Together with the Black Nurse Collaborative, Increases Focus on Improving Advocacy for Underrepresented Groups in Nursing The organizations look to enhance opportunities for Black nurses and advance health equity (Black PR Wire) WALTHAM, Mass.–(BUSINESS WIRE)– Wolters Kluwer Health today announced a new collaboration with the Black Nurse Collaborative, (BNC) to help remove barriers and improve diversity […]

(BPRW) Bridging Health Gaps: Mamas 4 Life Campaign Shines Light on Doulas and Midwives’ Contributions to Improving Equitable Birth Outcomes for BIPOC Women | Press releases

(BPRW) Bridging Health Gaps: Mamas 4 Life Campaign Shines Light on Doulas and Midwives’ Contributions to Improving Equitable Birth Outcomes for BIPOC Women Maternal Health Campaign (Black PR Wire) In a powerful move to address the alarming disparities in maternal mortality rates among Black, Indigenous, and People of Color (BIPOC), the Mamas 4 Life maternal […]

(BPRW) Vivacelle Bio Announces Early Results of its Phase IIa Clinical Trial of VBI-S for Improving Hypovolemia Due to Sepsis | Press releases

(BPRW) Vivacelle Bio Announces Early Results of its Phase IIa Clinical Trial of VBI-S for Improving Hypovolemia Due to Sepsis (Black PR Wire) Kansas City, MO – Vivacelle Bio, Inc., a privately held company focused on the development of improved treatments for septic shock, today announced early results from its Phase IIa clinical trial of VBI-S in […]